Activist 13D/13G Filings - Marshall Wace North America L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-14
09:51 am
Sale
13GAcrivon Therapeutics Inc.
ACRV
Marshall Wace North America L.P.597,469
2.700%
-625,783decrease
(-51.16%)
View
2023-05-22
4:15 pm
Purchase
13GINSPIREMD INC
NSPR
Marshall Wace North America L.P.1,860,405
9.900%
1,860,405increase
(New Position)
View
2023-02-14
09:35 am
Purchase
13GAcrivon Therapeutics Inc.
ACRV
Marshall Wace North America L.P.1,223,252
5.900%
1,223,252increase
(New Position)
View